These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1823834)

  • 1. Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.
    Shapiro B; Sisson JC; Wieland DM; Mangner TJ; Zempel SM; Mudgett E; Gross MD; Carey JE; Zasadny KR; Beierwaltes WH
    J Nucl Biol Med (1991); 1991; 35(4):269-76. PubMed ID: 1823834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [131I]metaiodobenzylguanidine treatment of malignant pheochromocytoma: experience of the Rome group.
    Troncone L; Rufini V; Daidone MS; De Santis M; Luzi S
    J Nucl Biol Med (1991); 1991; 35(4):295-9. PubMed ID: 1823840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: a French multicenter study.
    Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
    J Nucl Biol Med (1991); 1991; 35(4):284-7. PubMed ID: 1823837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
    Schvartz C; Gibold C; Vuillemin B; Delisle MJ
    J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [131I]metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma.
    Lumbroso J; Schlumberger M; Tenenbaum F; Aubert B; Travagli JP; Parmentier C
    J Nucl Biol Med (1991); 1991; 35(4):288-91. PubMed ID: 1823838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results of [131]metaiodobenzylguanidine treatment in metastatic malignant pheochromocytoma.
    Colombo L; Lomuscio G; Vignati A; Dottorini ME
    J Nucl Biol Med (1991); 1991; 35(4):300-4. PubMed ID: 1823841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of pheochromocytoma with [131I]metaiodobenzylguanidine.
    Fischer M
    J Nucl Biol Med (1991); 1991; 35(4):292-4. PubMed ID: 1823839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of [131I]metaiodobenzylguanidine treatment in metastatic malignant phaeochromocytoma.
    Bestagno M; Pizzocaro C; Maira G; Terzi A; Panarotto MB; Guerra P
    J Nucl Biol Med (1991); 1991; 35(4):277-9. PubMed ID: 1823835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication.
    Hoefnagel CA; Schornagel J; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):308-12. PubMed ID: 1823843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma.
    Hutchinson RJ; Sisson JC; Miser JS; Zasadny KR; Normolle DP; Shulkin BL; Francis IR; Wieland DM; Shapiro B
    J Nucl Biol Med (1991); 1991; 35(4):237-40. PubMed ID: 1823826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Session on the role of [131I]metaiodobenzylguanidine in the treatment of malignant phaeochromocytoma. Chairmen's report.
    Ackery DM; Troncone L
    J Nucl Biol Med (1991); 1991; 35(4):318-20. PubMed ID: 1823846
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
    Rose B; Matthay KK; Price D; Huberty J; Klencke B; Norton JA; Fitzgerald PA
    Cancer; 2003 Jul; 98(2):239-48. PubMed ID: 12872341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of malignant pheochromocytoma with a new radiopharmaceutical.
    Sisson J; Shapiro B; Beierwaltes WH; Nakajo M; Glowniak J; Mangner T; Carey JE; Swanson DP; Copp J; Satterlee W
    Trans Assoc Am Physicians; 1983; 96():209-17. PubMed ID: 6679954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
    Fitzgerald PA; Goldsby RE; Huberty JP; Price DC; Hawkins RA; Veatch JJ; Dela Cruz F; Jahan TM; Linker CA; Damon L; Matthay KK
    Ann N Y Acad Sci; 2006 Aug; 1073():465-90. PubMed ID: 17102115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.
    Matthay KK; Huberty JP; Hattner RS; Ablin AR; Engelstad BL; Zoger S; Hasegawa BH; Price D
    J Nucl Biol Med (1991); 1991; 35(4):244-7. PubMed ID: 1823827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of [131I]metaiodobenzylguanidine in the treatment of medullary thyroid carcinoma: results in five cases.
    Troncone L; Rufini V; Maussier ML; Valenza V; Daidone MS; Luzi S; De Santis M
    J Nucl Biol Med (1991); 1991; 35(4):327-31. PubMed ID: 1823849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid.
    Bestagno M; Pizzocaro C; Pagliaini R; Rossini PL; Guerra P
    J Nucl Biol Med (1991); 1991; 35(4):343-5. PubMed ID: 1823854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [131I]metaiodobenzylguanidine therapy in paraganglioma.
    Castellani MR; Rottoli L; Maffioli L; Massimino M; Crippa F; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):315-7. PubMed ID: 1823845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of [131I]metaiodobenzylguanidine therapy in medullary thyroid carcinoma.
    Hoefnagel CA; Delprat CC; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):334-6. PubMed ID: 1823851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.